Načítá se...
Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development
Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT associated gene, PMP22, the technological advancement in molecular genetics and gene technology has allowed...
Uloženo v:
| Vydáno v: | J Neurol Neurosurg Psychiatry |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327864/ https://ncbi.nlm.nih.gov/pubmed/30018047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-318834 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|